243 related articles for article (PubMed ID: 14531265)
1. [Heparin resistance during cardiopulmonary bypass].
Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
Barnette RE; Shupak RC; Pontius J; Rao AK
Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
[TBL] [Abstract][Full Text] [Related]
4. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
5. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
Kanbak M
Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
[TBL] [Abstract][Full Text] [Related]
6. [Heparin resistance associated with elevated factor VIII].
Kumano N; Ikeda S; Arimori Y; Ono T; Saeki S
Masui; 2008 Apr; 57(4):471-3. PubMed ID: 18416208
[TBL] [Abstract][Full Text] [Related]
7. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
Kanbak M; Oc B; Salman MA; Ocal T; Oc M
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass.
Huyzen RJ; van Oeveren W; Wei F; Stellingwerf P; Boonstra PW; Gu YJ
Ann Thorac Surg; 1996 Aug; 62(2):533-7. PubMed ID: 8694618
[TBL] [Abstract][Full Text] [Related]
9. A case report of heparin resistance due to acquired antithrombin III deficiency.
Leong CK; Ong BC
Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
Heller EL; Paul L
J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
[TBL] [Abstract][Full Text] [Related]
11. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
[TBL] [Abstract][Full Text] [Related]
12. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting.
Cloyd GM; D'Ambra MN; Akins CW
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):535-8. PubMed ID: 3498862
[TBL] [Abstract][Full Text] [Related]
13. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia after coronary artery bypass grafting with cardiopulmonary bypass: report of a case.
Ishida K; Imamaki M; Ishida A; Shimura H; Miyazaki M
Surg Today; 2004; 34(12):1041-3. PubMed ID: 15580389
[TBL] [Abstract][Full Text] [Related]
15. How much heparin do we really need to go on pump? A rethink of current practices.
Shuhaibar MN; Hargrove M; Millat MH; O'Donnell A; Aherne T
Eur J Cardiothorac Surg; 2004 Nov; 26(5):947-50. PubMed ID: 15519187
[TBL] [Abstract][Full Text] [Related]
16. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
17. Implications for cardiac surgery in patients with factor XII deficiency.
Conaglen PJ; Akowuah E; Theodore S; Atkinson V
Ann Thorac Surg; 2010 Feb; 89(2):625-6. PubMed ID: 20103363
[TBL] [Abstract][Full Text] [Related]
18. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
Cankovic L; Steenwyk BL; McGiffin DC; Nielsen VG
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):725-6. PubMed ID: 18832918
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.
Lemmer JH; Despotis GJ
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):213-7. PubMed ID: 11828278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
